- Home
- TNON vs BDRX Comparison
TNON vs BDRX Comparison
Compare TNON & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNON
- BDRX
- Stock Information
- Founded
- TNON 2012
- BDRX 2000
- Country
- TNON United States
- BDRX United Kingdom
- Employees
- TNON N/A
- BDRX N/A
- Industry
- TNON Medical Specialities
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- TNON Health Care
- BDRX Health Care
- Exchange
- TNON Nasdaq
- BDRX Nasdaq
- Market Cap
- TNON 3.2M
- BDRX 3.7M
- IPO Year
- TNON 2022
- BDRX N/A
- Fundamental
- Price
- TNON $1.17
- BDRX $1.55
- Analyst Decision
- TNON Strong Buy
- BDRX
- Analyst Count
- TNON 3
- BDRX 0
- Target Price
- TNON $11.67
- BDRX N/A
- AVG Volume (30 Days)
- TNON 1.1M
- BDRX 1.2M
- Earning Date
- TNON 05-13-2025
- BDRX 05-02-2025
- Dividend Yield
- TNON N/A
- BDRX N/A
- EPS Growth
- TNON N/A
- BDRX N/A
- EPS
- TNON N/A
- BDRX N/A
- Revenue
- TNON $3,277,000.00
- BDRX N/A
- Revenue This Year
- TNON $118.16
- BDRX N/A
- Revenue Next Year
- TNON $14.25
- BDRX N/A
- P/E Ratio
- TNON N/A
- BDRX N/A
- Revenue Growth
- TNON 11.92
- BDRX N/A
- 52 Week Low
- TNON $0.91
- BDRX $1.14
- 52 Week High
- TNON $15.79
- BDRX $74.00
- Technical
- Relative Strength Index (RSI)
- TNON 46.02
- BDRX 43.94
- Support Level
- TNON $1.06
- BDRX $1.24
- Resistance Level
- TNON $1.19
- BDRX $1.52
- Average True Range (ATR)
- TNON 0.11
- BDRX 0.20
- MACD
- TNON -0.01
- BDRX 0.07
- Stochastic Oscillator
- TNON 51.67
- BDRX 49.21
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants, and 3) SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines. The company combines approved and developed medications with its proprietary and drug delivery technologies to provide compelling products that have the potential to powerfully impact the lives of patients.